Back to 
Morgan Stanley
Morgan Stanley
SNOA8 quarters
Position history for Morgan Stanley's holdings in Sonoma Pharmaceuticals, Inc.
Yes. Morgan Stanley holds 2,000 shares of SNOA (Sonoma Pharmaceuticals), worth $2,460, as of its Q2 2026 13F filing. It reduced the position by 4 shares (-0.2%) from Q1 2026. Morgan Stanley has held SNOA since Q3 2024, across 8 quarterly 13F filings.
Current Value
$2,460
Current Shares
2,000
Total Value Change
+$2,448
Total Shares Change
+1,996
Quarter-by-Quarter History
Other major holders of SNOA: Vanguard Group Inc., Geode Capital Management, LLC, Renaissance Technologies LLC